|
|
||||||||
-Chymase Reduces IgE Recognition of Birch Pollen Profilin by Cleaving Antibody-Binding Epitopes1

*
Cardiovascular Research Institute and
Department of Medicine, University of California, San Francisco, CA 94143
| Abstract |
|---|
|
|
|---|
-chymase and other serine proteases. In birch and other
plant pollens, a major allergen is profilin. In mammals, profilin
homologues are found in an intracellular form bound to cytoskeletal or
cytosolic proteins or in a secreted form that may initiate signal
transduction. IgE specific to birch profilin also binds human profilin
I. This cross-reactivity between airborne and endogenous proteins may
help to sustain allergy symptoms. The current work demonstrates that
cultured mast cells constitutively secrete profilin I, which is
susceptible to degranulation-dependent proteolysis. Coincubation of
chymase-rich BR mastocytoma cells with
Ala-Ala-Pro-Phe-chloromethylketone (a chymase inhibitor) blocks
profilin cleavage, which does not occur in degranulated HMC-1 mast
cells, which are rich in tryptase, but chymase deficient. These data
implicate chymase as the serine protease cleaving secreted mast cell
profilin. Sequencing of chymase-cleaved profilins reveals hydrolysis at
Tyr6-Val7 and
Trp35-Ala36 in birch profilin and at
Trp32-Ala33 in human profilin, with all sites
lying within IgE-reactive epitopes. IgE immunoblotting studies with
sera from birch pollen-allergic individuals demonstrate that cleavage
by chymase attenuates binding of birch profilin to IgE. Thus,
destruction of IgE-binding epitopes by exocytosed chymase may limit
further mast cell activation by this class of common plant allergens,
thereby limiting the allergic responses in sensitized
individuals. | Introduction |
|---|
|
|
|---|
Intracellular profilins play roles in microfilament dynamics. The roles of secreted profilins are less clear, but data suggest that they can activate extracellular signaling pathways. Plant and mammalian profilins bind actin monomer, phosphatidylinositol-4,5-bis-phosphate, poly(L-proline), formin, and vasodilator-stimulated phosphoprotein via different sites, which enables them to participate in a variety of processes, such as cytoskeletal organization and cell signaling. Two isoforms of mammalian profilins demonstrate similar binding affinities, but have distinct expression patterns and specific ligand interactions, suggesting unique functions for each isoform in vivo. Death of profilin I-null murine embryos at the two-cell stage and reduced survival of heterozygotes suggest a critical role for profilin I early in development (9, 10). Extracellular accumulation and overexpression of profilins may also occur in tissues surrounding glomerular mesangial cells in rats with anti-Thy-1.1-induced glomerulonephritis. Secreted profilins may initiate signal transduction and regulate cell growth, as demonstrated by studies of cultured rat mesangial cells, in which profilin increases [3H]thymidine incorporation, enhances binding of AP-1 to DNA, and activates protein kinase C (11). One pathway for secretion of profilins occurs via release of exosomes by dendritic cells (12). Thus, secretion of profilin by mesenchymal cells may regulate local cell-cell interactions and cell signaling.
A shared topology and tertiary structure is the presumed basis for
extensive IgE cross-reactivity among mammalian and plant profilins
despite the low degree of primary sequence homology. Whereas plant
profilins are <25% identical with mammalian profilins in amino acid
sequence, all are thought to adopt a similar fold consisting of
anti-parallel
-sheets associated with
helixes. Epitopes
clustered at the NH2- and COOH-terminal
helixes and in a two-stranded segment (composed of residues 3050)
provide the basis for profilin immunogenicity and cross-reactivity.
This distribution of reactive epitopes permits simultaneous binding of
multiple IgE Abs necessary for receptor aggregation. Such
characterization of the three epitopes explains why 20% of
pollen-allergic individuals demonstrate cross-sensitization toward
pollen profilins from distantly related trees, grasses, and weeds.
Cross-reactivity of birch pollen profilin-specific IgE toward human
profilin I probably results from epitopes located in the
NH2-terminal
helix and the two-stranded
segment (7). In the present work we explore mast cell
release of profilin and identify sites in profilin cleaved by
-chymase, a chymotryptic mast cell serine protease.
| Materials and Methods |
|---|
|
|
|---|
BR mastocytoma cells (a canine mast cell line obtained from S. Lazarus, University of California, San Francisco, CA) or HMC-1 cells (a human mast cell line obtained from J. Butterfield, Mayo Clinic, Rochester, MN) were cultured in DMEM-H16 supplemented with 2% bovine calf serum or IMEM with 10% FCS, respectively, as previously described (13). Cells were maintained at a final concentration of 1 x 106 cells/ml and incubated at 37°C in humidified 5% CO2 and 95% air. Cells were harvested by centrifuging at 800 x g for 5 min, washing three times in Ca2+- and Mg2+-free PBS, and resuspending in serum-free culture medium to a final concentration of 45 x 106 cells/ml.
Degranulation studies
HMC-1 or BR cells were resuspended in phenol red-free culture medium in the absence or the presence of serum to a final concentration of 2 or 8 x 106 cells/ml, respectively. Cells were incubated at 37°C for different time periods alone, with 2 µM calcium ionophore A23187 (Sigma, St. Louis, MO), or with ionophore in combination with a protease inhibitor cocktail (Sigma), 10 mM PMSF (Sigma), or 25 µM Ala-Ala-Pro-Phe-chloromethylketone (AAPF-CMK3; Enzyme Systems Products, Livermore, CA). Aliquots removed at specified intervals were centrifuged at 800 x g to pellet cells. Cell supernatants were stored at -20°C before analysis by immunoblotting. Cytotoxicity of degranulation studies was determined by assaying the amount of lactic dehydrogenase (LDH) present in supernatants using the In Vitro Toxicology Assay Kit (Sigma) according to the manufacturers protocol. The tryptase content of HMC-1 cells is 175 ± 15 ng/106 cells based on hydrolysis of 0.1 mM tosyl-L-Gly-Pro-Lys-p-Na in 50 mM Tris-HCl buffer (pH 7.6) containing 0.12 M NaCl and 20 µg/ml bovine lung heparin (Sigma) at 37°C (14).
Immunoblotting
Aliquots of mast cell-conditioned medium, cell lysates or degranulation supernatants, partially purified proteins, or purified recombinant birch pollen (BIOMAY, Linz, Austria) or purified human platelet (Cytoskeleton, Denver, CO) profilins were electrophoresed onto a 12% bis-Tris gel and blotted onto Polyscreen polyvinylidene difluoride membrane (NEN Life Science Products, Boston, MA). Membranes were washed in 10 mM Tris-HCl (pH 7.5) buffer containing 150 mM NaCl and 0.3% Tween 20 and incubated with rabbit polyclonal anti-human profilin I (which cross-reacts with profilin I of other mammalian species in Cytoskeletons quality control assays) at 22°C for 30 min. Membranes were then incubated with HRP-linked anti-rabbit Ig for 30 min and washed three times in 10 mM Tris-HCl (pH 7.5) buffer containing 150 mM NaCl and 0.3% Tween 20. Immunoreactive proteins were detected by chemiluminescence using Luminol and peroxidase reagents in the Phototope-HRP Western Blot Detection kit (New England Biolabs, Beverly, MA) according to the manufacturers protocols and visualized on Hyperfilm ECL (Amersham Pharmacia Biotech, Piscataway, NJ).
Purification
HMC-1 cells (4.5 x 109) were harvested by centrifuging at 800 x g for 5 min and washing three times in Ca2+- and Mg2+-free PBS. Cells were then incubated in 50 mM HEPES (pH 7.4) and 150 mM NaCl with 10% glycerol, 1 mM PMSF, 25 µM leupeptin, 1.5 µM aprotinin, and 10 mM 1,10-phenanthroline to inhibit protease activity before sonication. Following centrifugation at 36,000 x g to remove cells and debris, cell lysate supernatants were stored at -20°C before use. Supernatants equilibrated to 0.5 M NaCl were loaded onto a DEAE-cellulose (Sigma) column equilibrated with 10 mM Tris-HCl buffer (pH 7.5) containing 0.5 M NaCl. Unbound proteins in flow-through fractions were diluted in 20 mM Tris-HCl buffer (pH 7.5) to a final concentration of 0.12 M NaCl and loaded onto a heparin-Sepharose CL-6B (Amersham Pharmacia Biotech) column equilibrated in 20 mM Tris-HCl buffer (pH 7.5). Aliquots of the heparin column loading flow-through were exchanged into 10 mM bis-Tris buffer (pH 6.1) containing 20% glycerol and concentrated using a Centricon Plus-20 centrifugal filter device (Millipore, Bedford, MA) with a 10 kDa Mr cut-off before loading onto a Mono S fine performance liquid chromatography column (Amersham Pharmacia). Proteins in flow-through fractions were concentrated as described above and loaded onto a Mono Q fine performance liquid chromatography column (Amersham Pharmacia). Unbound proteins in the flow-through were subjected to continuous elution electrophoresis using a Mini Prep Cell (Bio-Rad, Hercules, CA). Proteins were electrophoresed through a vertical 5-cm x 1-cm 14% Tris-glycine polyacrylamide cylindrical gel with migration off the bottom of the gel into a collection tube, which enabled isolation of proteins of different sizes in individual fractions. Eluted protein fractions were stored at -20°C before use.
NH2-terminal sequencing
Purified protein was electrophoresed onto a 16% Tris-glycine
polyacrylamide gel and blotted onto sequencing grade polyvinylidene
difluoride (PVDF) membrane (Bio-Rad) in
3-[cyclohexylamino]-1-propanesulfonic acid buffer containing 10%
methanol. To prepare peptide fragments for internal sequencing by
chemical digestion at internal tryptophan residues, in situ cleavage of
PVDF-bound proteins was performed by incubating membrane fragments in
75% acetic acid containing 1 µg/µl
3-bromo-3-methyl-2-(2'-nitrophenylmercapto)-3H-indole (BNPS-skatole) at
47°C for 1 h (15). Proteins bound to dried membrane
strips were eluted by incubation in 70% isopropyl alcohol containing
5% trifluoroacetic acid at 22°C for 16 h. Peptide fragments
from BNPS-skatole digestion were electrophoresed onto a 16%
Tris-glycine polyacrylamide gel and blotted onto sequencing grade PVDF
membrane as described above. Cleavage products resulting from
-chymase hydrolysis were electrophoresed onto a 12% bis-Tris
polyacrylamide gel and blotted onto sequencing grade PVDF membrane in
25 mM bicine buffer (pH 7.2) containing 25 mM bis-Tris, 1.0 mM EDTA,
0.05 mM chlorobutanol, and 15% methanol. Protein bands identified by
Coomassie blue staining of the membrane were excised and subjected to
Edman degradation for determination of amino acid sequence by Midwest
Analytical (St. Louis, MO), using a model 477A protein sequencer
(Applied Biosystems, Foster City, CA). Protein sequence alignments were
performed using MacVector software (Oxford Molecular Group, Hunt
Valley, MD).
Substrate cleavage
Purified human platelet profilin I (Cytoskeleton) or recombinant
birch pollen profilin (BIOMAY) was incubated with various
concentrations of purified recombinant human
-chymase
(16) (gift from G. Caughey) or purified recombinant human
-tryptase (Promega, Madison, WI) at 37°C for 18 h. Reaction
products were electrophoresed onto 12% bis-Tris polyacrylamide gels
and subjected to staining with Coomassie blue or immunoblotting.
IgE immunoblotting
Detection of binding of birch pollen profilin-specific IgE to
reactive epitopes in PVDF membrane-bound recombinant birch profilin was
performed as previously described (5, 17, 18, 19). Briefly,
native or
-chymase-cleaved purified recombinant birch profilin
(BIOMAY) was electrophoresed onto 12% bis-Tris polyacrylamide gels and
transferred to PVDF as described above. Ninety percent of protein in
either reaction was allocated for immobilization on PVDF membranes for
immunoblotting, while 10% was reserved for SDS-PAGE with detection of
proteins by Coomassie blue staining. Membranes were blocked by
incubation in 5% nonfat dry milk in PBS at 37°C for 1 h, washed
in 10 mM Tris-HCl (pH 7.5) buffer containing 150 mM NaCl (TBS), and
incubated in human serum (diluted 1/1 in PBS) from either individuals
allergic to birch pollen (National Institute for Biological Standards
and Control, Potters Bar, U.K.) or nonallergic individuals (Sigma) at
4°C for 16 h. After washing three times in TBS, detection of
bound IgE was performed by incubating membranes with HRP-linked mouse
anti-human IgE (Zymed, South San Francisco, CA) in TBS containing
0.3% Tween 20 at 22°C for 30 min, followed by chemiluminescent
detection as described above. To determine the sensitivity of detection
of native birch profilin, various dilutions of protein were analyzed by
IgE immunoblotting with the establishment of a lower limit of detection
threshold of approximately 200 ng protein/lane.
| Results |
|---|
|
|
|---|
Accumulation of profilin in the extracellular matrix and its
secretion by stromal cells (11, 12) suggested the
likelihood that mast cells (which are noncirculating inflammatory cells
resident in tissues) may also secrete profilin. Our prior work has
established that cultured HMC-1 cells and BR mastocytoma cells
phenotypically resemble human mast cells in their complement of stored
and secreted mediators (13, 16, 20, 21, 22). To determine
whether mast cells may release endogenous profilins, cells were
cultured in medium without serum for various periods. As shown in Fig. 1
, unconcentrated medium conditioned by
HMC-1 or BR mastocytoma cells incubated for 5 min contains an
approximately 15-kDa band immunoreactive for profilin, suggesting
constitutive release of the protein. Incubation of cells with calcium
ionophore A23187 increases the intensity of the immunoreactive band
present in HMC-1 or BR supernatants within 5 min, suggesting that rapid
degranulation induces release of profilin. Since levels of LDH released
by cells incubated in the presence of ionophore were similar to those
from cells incubated alone, differences in cell cytotoxicity do not
account for increased amounts of profilin in degranulation
supernatants. Profilin-immunoreactive bands were absent in
serum-containing cell culture medium (data not shown). Thus, neither
cell lysis nor contamination by serum proteins explains the presence of
profilin in mast cell supernatants. These data suggest that mast cells,
like other stromal cells such as dendritic (12) or
mesangial cells (11), may release profilins into the
extracellular milieu.
|
Identification of protein immunoreactive for profilin I in medium
conditioned by cultured mast cells suggested both constitutive and
degranulation-induced release of stored protein. Although bound to
cytoskeletal and signaling proteins, profilin is also secreted in
uncomplexed form by stromal cells (12). Immunoreactive
protein present in membrane-free HMC-1 cell lysates was purified to
isolate the unbound form and to establish its identity as profilin.
Potential interference of abundant proteoglycan stored in secretory
granules required similar chromatographic approaches previously used
successfully in the purification of other mast cell proteins in our
laboratory (20, 23). As shown in Fig. 2
, purification required sequential anion
and cation exchange chromatography to remove contaminants. While some
immunoreactive protein bound to each of the chromatographic columns
(data not shown), the majority of the immunoreactive protein flowed
through each column. Immunoblot analysis identified profilin in
fractions from each of the chromatographic steps, as shown in Fig. 2
A. Coomassie staining of fractions collected during
continuous elution electrophoresis identified fractions containing
profilin-immunoreactive protein free of contaminants, with an
electrophoretic profile identical with that of purified human profilin
I and the immunoreactive band present in serum-free HMC-1-conditioned
medium, as shown in Fig. 2
B.
|
To establish the identity of the immunoreactive band, aliquots of
protein purified from HMC-1 cell lysates were subjected to Edman
degradation, which revealed a blocked
NH2-terminal residue. To obtain internal sequence
data, purified protein was digested with BNPS-skatole, which cleaves at
tryptophan residues (15). Edman degradation of protein
fragments resulting from digestion with BNPS-skatole yielded two
overlapping sequences, AAVPG and AAVPGKTFVN, and an additional
sequence, XAYID, as shown in Fig. 3
. No
residue was assigned to cycle 1 of the last sequence due to
insufficient discrimination of chromatographic peak amplitudes from the
subsequent cycle. Analysis of these fragments by searching BLAST
databases suggested the identity of the protein as human profilin I.
Alignment of the first two sequences with the primary sequence of human
profilin I identifies cleavage at Trp32, while
alignment of the third sequence identifies additional hydrolysis at
Trp4. Thus, these data establish the identity of
the purified mast cell protein as profilin I. The presence of a blocked
NH2-terminal residue in purified native protein
is consistent with prior work demonstrating blockage of the
NH2-terminus of both mammalian and amoeba
profilins (24). Thus, the purification scheme enables
successful isolation of uncomplexed profilin I from mast cells whose
complement of cytosolic and granular proteins, including proteoglycans,
often requires a succession of chromatographic steps to isolate protein
from extracts (20, 21, 22, 23).
|
Mast cell degranulation during allergy and inflammatory responses
releases a variety of mediators, including tryptase and
-chymase,
which are tryptic and chymotryptic serine proteases, respectively.
Since proteolysis may affect the stability of allergens
(25), we explored the effect of degranulation on mast cell
expression of profilin. Degranulation altered the electrophoretic
profile of immunoreactive bands in supernatants of BR mastocytoma cells
incubated in the presence of calcium ionophore A23187. In addition to
revealing the 15-kDa native profilin band, immunoblotting of
degranulation supernatants detected a band at about 10 kDa whose
intensity increases with prolonged incubation, as shown in Fig. 4
A. Similar degranulation
experiments performed with HMC-1 cells do not yield the lower band
(data not shown), suggesting that their lack of
-chymase expression
(26) may explain the absence of profilin processing. The
lack of the approximately 10-kDa band in the supernatants of cells
incubated alone, even after 4 h, further supports a requirement
for degranulation for its appearance. To identify the protease(s)
involved in degranulation-associated profilin processing, cells were
incubated with calcium ionophore alone or in combination with PMSF, a
general serine protease inhibitor, or AAPF-CMK, a specific inhibitor of
-chymase. Coincubation of cells with calcium ionophore and either
PMSF or AAPF-CMK blocks the appearance of the approximately 10-kDa
band. By contrast, coincubation in the presence of E64 or
1,10-phenanthroline did not block its appearance, suggesting the lack
of hydrolysis by cysteine or metalloproteinases, respectively (data not
shown). As shown in Fig. 4
B, degranulation-induced
chymase-dependent cleavage of profilin also occurs in the presence of
serum proteins. Although abundant in mast cells (27),
tryptase appears to have a minimal effect on profilin processing, as
demonstrated by the minor cleavage of birch profilin by tryptase
compared with that by
-chymase, as shown in Fig. 4
C, by
the ability of AAPF-CMK (which inhibits
-chymase, but not tryptase)
alone to block the appearance of the lower band, and by the inability
of bis(5-amidino-2-benzimidazolyl) methane (a specific inhibitor of
tryptase) to block the appearance of the approximately 10-kDa band
(data not shown). No significant differences in LDH release were
observed between cells incubated alone or in the presence of calcium
ionophore (without or with inhibitors), suggesting no increase in
cytotoxicity in degranulating cells. Thus, these data identify
-chymase as the serine protease responsible for cleavage of mast
cell profilin during degranulation.
|
-Chymase cleaves profilin
To determine whether mast cell
-chymase cleaves profilins
generally, we characterized the electrophoretic profile of birch pollen
profilin, human profilin I, or purified mast cell profilin following
incubation with purified human
-chymase. As shown in Fig. 5
A, incubation of
-chymase
with birch profilin yields three bands at approximately 10, 6, and 3
kDa. By contrast, cleavage of human profilin I results in the
appearance of two bands at approximately 10 and 6 kDa, with a similar
electrophoretic profile identified for cleaved mast cell profilin.
Incubation of
-chymase with birch profilin at a molar ratio of
1:20,000 yields a faint 10-kDa product, with generation of the 6- and
3-kDa products with increasing protease concentration. By contrast,
similar molar ratios of
-chymase cleave human profilin to a lesser
degree, as shown in Fig. 5
B.
NH2-terminal sequencing of the 10-kDa birch
profilin cleavage product (band a) yields two sequences (VDEHL and
AQSSX1F). Similar analysis of the 6-kDa band
yields the same pair of sequences, suggesting truncation due to
cleavage in the COOH-terminal domain. Edman degradation of the 3-kDa
band (band c) yields two sequences (MVIQG and
AQSSX1F) in approximately a 4:1 molar ratio. As
shown in Fig. 5
C, alignment of these sequences with the
primary sequence of birch pollen profilin (7) reveals that
-chymase cleaves the
Tyr6-Val7,
Trp35-Ala36, and
Tyr74-Met75 bonds.
NH2-terminal sequencing of the 10- and 6-kDa
cleavage products (bands d and e, respectively) of human profilin I
yields two sequences (AAVPGKX2FV and VNGLT) whose
alignment to the primary sequence (28) identifies
Trp32-Ala33 and
Tyr59-Val60 as the bonds
cleaved by
-chymase. No residues were assigned to position
X1 or X2 due to
insufficient discrimination of chromatographic peak amplitudes in
successive cycles. The P1 residues of each of the scissile bonds is
aromatic (Tyr or Trp), as preferred by chymotryptic enzymes
(29). Whereas the
Tyr6-Val7 bond is situated
in the NH2-terminal
helix of birch profilin,
the Trp35-Ala36 or
Trp32-Ala33 bonds are
located in the two-stranded segments (approximately residues 3050) of
birch or human profilin, respectively. These scissile bonds cleaved by
-chymase are situated in regions identified to be IgE-reactive
epitopes and localized to the surface of profilins, as shown in Fig. 6
B. By contrast, cleavage at
the Tyr74-Met75 or
Tyr59-Val60 bonds of birch
or human profilin, respectively, occurs in a nonepitopic
strand
(based on a structure-based sequence alignment), which is also exposed
at the surface (data not shown) (7).
|
|
Immunoblotting of pollen extracts or purified allergen proteins
using sera from sensitized individuals enables detection of
allergen-specific IgE Ab bound to reactive epitopes. The use of control
serum from nonallergic individuals establishes the specificity of the
binding of IgE present in allergic serum, while preadsorption of
allergic sera with purified allergens in IgE inhibition experiments may
identify cross-sensitization of individuals to allergens in unrelated
trees, weeds, or grasses (5, 17, 18, 19). To determine the
effect of
-chymase hydrolysis of birch profilin on binding of
allergen-specific IgE, immunoblotting of native or
-chymase-cleaved
birch profilin was performed using serum from individuals allergic to
birch pollen. As shown in Fig. 7
A, incubation of
-chymase
with birch profilin in a 1:2000 molar ratio yields three cleavage
products detectable by Coomassie blue staining. Immunoblotting using
allergic serum identified an approximately 14-kDa immunoreactive band
in the lane containing uncleaved, native birch profilin, as shown in
Fig. 7
B. By contrast, no immunoreactive bands were seen in
the lane containing
-chymase-cleaved profilin. In addition, no
immunoreactive bounds were detected in either lane containing native or
cleaved profilin in immunoblots incubated with control human serum. To
ensure that immunoblotting was performed under conditions of an excess
of membrane-bound allergen protein, native and
-chymase-cleaved
profilin were apportioned to SDS-PAGE or immunoblotting unevenly, with
the bulk of protein in each reaction allocated for immobilization to
membrane. Moreover, quantities of Coomassie blue-detectable cleavage
products allocated for immunoblotting far exceeded the immunoblot
detection sensitivity of the native profilin protein. Thus, the lack of
sufficient quantities of
-chymase-cleaved profilin products does not
explain the absence of immunoreactive bands in the lane containing
cleavage products. Therefore, these data suggest that cleavage of birch
profilin by
-chymase attenuates binding of allergen-specific
IgE.
|
| Discussion |
|---|
|
|
|---|
-chymase, a chymotryptic serine protease, may
preferentially cleave birch pollen profilin, thus altering its surface
display of IgE-reactive epitopes.
Degranulation of mast cells induces the release of profilin and
synchronous proteolysis of the secreted protein. Cultured mast cells
such as HMC-1 or BR mastocytoma cells secrete profilin constitutively,
yet increase their release of profilin upon degranulation with calcium
ionophore. Prolonged degranulation results in profilin cleavage, which
is blocked by specific inhibitors of
-chymase (a chymotryptic mast
cell serine protease), thus identifying it as the protease responsible
for extracellular cleavage of secreted profilin. The absence of similar
profiles in supernatants of
-chymase-deficient HMC-1 cells
(26) substantiates the observed mechanism of extracellular
profilin processing. These data suggest that quiescent or activated
mast cells may contribute and process profilins in normal or inflamed
tissues. Immunohistochemical analysis of nasal mucosa biopsies from
subjects with birch pollen allergy show a seasonal diminution in the
quantity of detectable
-chymase-expressing mast cells, providing
clinical evidence that asynchronous secretion (3) or
selective degranulation of
-chymase may occur, relative to tryptase.
Reductions in
-chymase-positive cells (without changes in the
numbers of tryptase-positive cells) also occur in patients with
seasonal rhinitis following challenge with grass pollen, further
supporting the preferential release of
-chymase as part of the
allergic response (30). The release of profilin via
secretion of membrane vesicles known as exosomes may be a mechanism
that enables mast cells to release profilin. In addition to binding to
intracellular cytoskeletal proteins or signaling factors, profilin is
present in exosomes secreted constitutively by murine dendritic cells
(12). Evidence of similar secretion of exosomes by
cultured mast cell lines P815 and MC/9 and IL-4-treated murine bone
marrow-derived mast cells (31) suggests that profilin
release from HMC-1 or BR cells may also occur via exosomes. Therefore,
stromal mast cells may contribute profilins to the extracellular
milieu, while subpopulations of allergen-sensitized mast cells may
degranulate
-chymase, which may result in cleavage of stromal
profilin.
Similarities in the amino acid sequences of IgE-reactive epitopes
hydrolyzed by
-chymase suggest that its differential cleavage of
birch pollen profilin and human profilin I may be explained by a
difference in their otherwise highly homologous tertiary structure.
Since both profilins undergo cleavage in a surface-accessible
strand, increased susceptibility of birch profilin to
-chymase
cleavage probably results from the accessibility of both the
Tyr6-Val7 and
Trp35-Ala36 scissile bonds
compared with Trp32-Ala33
alone in human profilin I. Although the human protein contains the
homologous Tyr7-Ile8
scissile bond, peptide sequencing of
-chymase-cleaved products did
not yield evidence of such hydrolysis. Substitution of Ile for Val in
the human sequence in the P1' position is not expected to alter the
preference of
-chymase for the P1 Tyr residue (29).
Moreover, like birch profilin Tyr6, human
profilin Tyr7 localizes to the molecular surface.
Thus, neither the primary sequences nor surface localization explain
the preferential cleavage of birch profilin by
-chymase. By
contrast, selective cleavage of the
Tyr6-Val7 bond of birch
profilin may occur due to its location in the
NH2-terminal IgE-reactive region. Crystal
structure analysis of the birch protein reveals displacement and
increased flexibility of the loop connecting the
NH2-terminal
helix to the first
strand,
compared with that present in mammalian or acanthamoeba profilins. The
different orientation of the NH2-terminal
helix disrupts a solvent-accessible hydrophobic patch (which includes
the Tyr and Trp residues of the scissile bonds) and leads to an open
configuration, as shown in Fig. 6
A (7). The
absence of a similar displacement in human profilin I suggests that the
homologous Tyr7-Ile8 bond
is sterically unavailable to
-chymase hydrolysis. Thus, displacement
of the NH2-terminal
helix in birch profilin
may favor
-chymase cleavage of either or both the
Tyr6-Val7 and
Trp35-Ala36 bonds.
Susceptibility to proteases may be an important determinant of
allergenicity, since hydrolysis may alter the physical and immunologic
properties of airborne proteins. Cleavage of domains containing
IgE-reactive epitopes in birch profilin may affect not only its
immunogenicity, but also IgE-dependent regulation of mast cell effector
functions during the allergic response. The capacity of proteins to
induce IgE production, bind IgE Ab, and trigger allergic symptoms in
sensitized individuals depends on properties such as affinity, epitope
valence, fold compactness, stability, proteolysis, solubility, and size
(25). Three prominent birch pollen profilin IgE-reactive
epitopes map to the NH2- and COOH-terminal
regions and an interposed two-strand region in a tertiary structure
highly conserved among plant and mammalian profilins despite low
primary sequence identity. The NH2-terminal
-helical region and the two-stranded segment contain the two
epitopes probably responsible for the cross-reactivity exhibited by
serum IgE of birch pollen-allergic individuals to endogenous human
profilin I (7, 32). Hydrolysis by mast cell
-chymase
occurs in these two regions and attenuates the ability of IgE in the
serum of allergic individuals to bind to cleaved birch profilin. By
contrast, the IgE-reactive epitope in the
NH2-terminal
-helical region of the human
protein appears to be sterically unavailable to
-chymase, although
cleavage does occur in its two-strand epitope region. Whether
hydrolysis also occurs in the third, COOH-terminal epitope
(7) is unclear, since neither sequencing nor
electrophoresis reveals evidence of such cleavage.
-Chymase
hydrolysis of two epitopic areas in birch profilin may not only alter
the critical properties of the native allergen, but may also expose
previously unavailable molecular surfaces containing new potential
epitopes. Decreased binding of IgE may also influence the activation of
effector cells such as mast cells. Binding of multiple IgE Abs to
polyvalent allergens such as birch profilin (7) induces
clustering of cell surface high IgE affinity Fc
RI receptors and the
subsequent activation and degranulation of mast cells. Cleavage-induced
attenuation of IgE binding to allergen may not only diminish mast cell
activation, but may also diminish the sensitivity and the magnitude of
the effector cell response, since IgE up-regulates the surface
expression of Fc
RI receptors via a positive feedback mechanism.
Therefore, attenuation of binding of IgE to allergens such as birch
profilin may regulate mast cell participation in acute, late phase, and
chronic allergic responses or disrupt interactions with other
leukocytes and cytokines via putative cascades that may promote or
propagate the inflammatory response (33).
In summary, our data demonstrate that degranulation enhances the
secretion of profilin from cultured mast cells, suggesting that
activated mast cells responding to allergens may contribute endogenous
profilins, perhaps via the release of exosomes.
-Chymase released by
degranulating mast cells cleaves birch pollen profilin at two scissile
bonds containing aromatic residues located in regions containing
IgE-reactive epitopes. Hydrolysis in these regions attenuates binding
of IgE, suggesting that the release of
-chymase may not only
attenuate the allergenicity of airborne profilins, but also alter the
temporal response of mast cells in allergic inflammation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Kenneth C. Fang, Box 0911, Cardiovascular Research Institute, University of California, San Francisco, CA 94143-0911. E-mail address: kfang{at}itsa.ucsf.edu ![]()
3 Abbreviations used in this paper: AAPF-CMK, Ala-Ala-Pro-Phe-chloromethylketone; BNPS-skatole, 3-bromo-3-methyl-2-(2'-nitrophenylmercapto)-3H-indole; LDH, lactic dehydrogenase; PVDF, polyvinylidene difluoride. ![]()
Received for publication August 24, 2001. Accepted for publication October 29, 2001.
| References |
|---|
|
|
|---|
-chymase. J. Immunol. 166:2783.
- and
-chymases. Biochim. Biophys. Acta. 1480:245.[Medline]
RI
, and Fc
RI
mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. 154:5472.[Abstract]
This article has been cited by other articles:
![]() |
G. H. Caughey, J. Beauchamp, D. Schlatter, W. W. Raymond, N. N. Trivedi, D. Banner, H. Mauser, and J. Fingerle Guinea Pig Chymase Is Leucine-specific: A NOVEL EXAMPLE OF FUNCTIONAL PLASTICITY IN THE CHYMASE/GRANZYME FAMILY OF SERINE PEPTIDASES J. Biol. Chem., May 16, 2008; 283(20): 13943 - 13951. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rauter, M.-T. Krauth, S. Flicker, A. Gieras, K. Westritschnig, S. Vrtala, N. Balic, S. Spitzauer, J. Huss-Marp, K. Brockow, et al. Allergen cleavage by effector cell-derived proteases regulates allergic inflammation FASEB J, May 1, 2006; 20(7): 967 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Cruz, B. T. Frank, S. T. Edwards, P. F. Dazin, J. J. Peschon, and K. C. Fang Tumor Necrosis Factor-{alpha}-converting Enzyme Controls Surface Expression of c-Kit and Survival of Embryonic Stem Cell-derived Mast Cells J. Biol. Chem., February 13, 2004; 279(7): 5612 - 5620. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Karlson, G. Pejler, B. Tomasini-Johansson, and L. Hellman Extended Substrate Specificity of Rat Mast Cell Protease 5, a Rodent {alpha}-Chymase with Elastase-like Primary Specificity J. Biol. Chem., October 10, 2003; 278(41): 39625 - 39631. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Raymond, S. W. Ruggles, C. S. Craik, and G. H. Caughey Albumin Is a Substrate of Human Chymase: PREDICTION BY COMBINATORIAL PEPTIDE SCREENING AND DEVELOPMENT OF A SELECTIVE INHIBITOR BASED ON THE ALBUMIN CLEAVAGE SITE J. Biol. Chem., September 5, 2003; 278(36): 34517 - 34524. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |